Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases

Atrial Flutter Clinical Trials

A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


Alaska

ARCA Clinical Research Site #157
Anchorage Alaska 99508

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

California

ARCA Clinical Research Site #320
Pasadena California 91105

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Colorado

ARCA Clinical Research Site #153
Aurora Colorado 80045

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Florida

ARCA Clinical Research Site #184
Tampa Florida 33606

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Georgia

Emory University Hospital Midtown
Atlanta Georgia 30308

A clinical trial seeking patients for a research study for the treatment of Cardiac Catheter Ablation, Atrial Flutter or Cardiac Arrhythmias

Emory University Hospital
Atlanta Georgia 30322

A clinical trial to evaluate treatments using Catheter ablation for patients with Atrial Flutter or Arrhythmia

Illinois

ARCA Clinical Research Site #194
Gurnee Illinois 60031

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Indiana

ARCA Clinical Research Site #303
Hammond Indiana 46320

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Michigan

ARCA Clinical Research Site #162
Lansing Michigan 48912

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

ARCA Clinical Research Site #105
Royal Oak Michigan 48703

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nebraska

ARCA Clinical Research Site #152
Lincoln Nebraska 68506

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

ARCA Clinical Research Site #176
Omaha Nebraska 68198

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New Jersey

ARCA Clinical Research Site #161
Elmer New Jersey 08318

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ohio

ARCA Clinical Research Site #151
Columbus Ohio 43210

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oklahoma

ARCA Clinical Research Site #123
Oklahoma City Oklahoma 73120

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pennsylvania

ARCA Clinical Research Site #109
Lancaster Pennsylvania 17603

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

ARCA Clinical Research Site #114
Wyomissing Pennsylvania 19610

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tennessee

ARCA Clinical Research Site #198
Jackson Tennessee 38305

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Vanderbilt University Medical Center
Nashville Tennessee 37232

A clinical research study of dabigatran etexilate mesylate for the treatment of Atrial Fibrillation or Atrial Flutter

Texas

ARCA Clinical Research Site #316
Austin Texas 78705

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

ARCA Clinical Research Site #160
Beaumont Texas 77702

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Virginia

ARCA Research Site #131
Norfolk Virginia 23507

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Washington

ARCA Clinical Research Site #196
Puyallup Washington 98372

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Bulgaria

Many Locations 1309

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Sofia 1309

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Varna 9010

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Canada

London Health Sciences Center
London Ontario N6A 5A5

A clinical trial to evaluate treatments using tricuspid isthmus imaging with Cartosound for patients with Atrial Flutter

France

Creteil 94010

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

CHU Grenoble
Grenoble 38000

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Many Locations 75012

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

CHU de Rennes
Rennes 35033

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

University Hospital of Rouen
Rouen 76000

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

View More »

Clinique Pasteur
Toulouse 31076

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Germany

Bonn Nordrhein-Westfalen 53105

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations Nordrhein-Westfalen 53105

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Universitiy Medical Centre Rostock
Rostock 18057

A clinical research study of Antiarrhythmic drug, Cavo-tricuspid-isthmus-ablation and Pulmonary vein isolation for the treatment of Atrial Fibrillation or Atrial Flutter

Poland

Krakow 31-121

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lodz 91-347

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lublin 20-954

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations 91-347

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Wroclaw 50-420

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Russian Federation

Many Locations 115093

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Turkey

Istanbul 34662

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Istanbul

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations 34846

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Samsun 55139

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Ukraine

Donetsk 83045

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Kiev 03680

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations 65025

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Uzhhorod 88000

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation